Advertisements
Advertisements
Question
What are recombinant DNA vaccines? Give two examples of such vaccines. Discuss their advantages.
Solution
A recombinant vaccine is a vaccine produced through recombinant DNA technology. This involves inserting the DNA encoding an antigen that stimulates an immune response into bacterial or mammalian cells. Recombinant DNA technology has allowed the production of antigenic polypeptides of pathogen in bacteria or yeast. Vaccines produced using this approach allow large-scale production and hence greater availability for immunisation, e.g., hepatitis B vaccine (Recombivax HB) produced from yeast. As of June 2015 one human DNA vaccine had been approved for human use, the single-dose Japanese encephalitis vaccine called IMOJEV, released in 2010 in Australia.
Advantages of recombinant DNA vaccines:
- No risk for infection
- Ease of development and production
- Stability for storage and shipping
- Cost-effectiveness
- Expression and purification of recombinant proteins
- Long-term persistence of immunogen
- In vivo expression ensures protein more closely resembles normal eukaryotic structure, with accompanying post-translational modifications.
APPEARS IN
RELATED QUESTIONS
What is vaccine?
Define the following:
Vaccine
Mention the contributions of
Louis Pasteur.
Name three commonly used vaccines.
Who discovered the first antibiotic?
Given below are the groups of certain substances of particular categories. Mention the category of each group and identify the wrong example giving reason.
Tears, skin, nasal secretion, HCl (in stomach)
Antibodies of white polio drops that are administered into the body contain:
What is NOT true about the purpose of vaccination?
What is the basic principle of vaccination? How do vaccines prevent microbial infections? Name the organism from which hepatitis B vaccine is produced.
Assertion: A person who has received a cut from a sharp object and is bleeding, needs to be given an anti-tetanus injection.
Reason: Anti-tetanus injection stimulates the production of antibodies for tetanus.
